HK Stock Movement | Kelun-Biotech (06990.HK) Rises Over 3% as Phase 2 Portion of POLARIS-1 Clinical Trial Achieves Positive Results and Phase 3 Trial Has Been Initiated
Zhito Finance APP has learned that Kelun-Biotech (06990.HK) rose more than 3%, up 3.35% as of press time, at HK$480.8, with a turnover of HK$253 million.
Latest
